Abstract 1 DNA immunization is a convenient and effective way of inducing a specific antibody 2 response. In mammals, co-administration of vectors encoding immunostimmulatory cytokines 3 can enhance the humoral response resulting in elevated antibody titers. We therefore set out to 4 investigate the effect using avian interleukin 1IL- and avian interleukin 6 (IL-6) as 5 genetic adjuvants when immunizing laying hens. A BoNT A1 holotoxoid DNA immunogen 6 carrying two inactivating mutations was evaluated for its ability to induce a specific and 7 sustained IgY antibody response. Both the holotoxoid and the cytokine sequences were 8 codon-optimized. In vitro, the proteins were efficiently expressed in transfected HEK 293T 9 cells and the cytokines were secreted into the culture supernatants. Whereas eggs from hens 10 immunized via gene gun using a prime boost strategy showed no differences in their total IgY 11 content, the specific BoNT A1 response was slightly elevated up to 1.4x by the IL-1 12 adjuvant vector and increased by 3.8x by the IL-6 vector. Finally, although hens receiving the 13 IL-1 adjuvant had laying capacities above the average, hens receiving the IL-6 adjuvant 14 experienced laying problems. 
Introduction 1
Inspired by a pioneering study by Paul Ehrlich (Ehrlich 1892), Klemperer immunized laying 2 hens with increasing doses of virulent Tetanus-Bouillon-Culture to test whether protective 3 antibodies exist not only in the blood but also in the egg (Klemperer et al. 1893 ). An extract 4 of yolk from eggs laid by these hens had a protective effect if mice were treated before 5 receiving a lethal dose of Tetanus-Bouillon-Culture. This demonstrated that neutralizing 6 antibodies were also transferred to the egg yolk as a form of "maternal immunity". However, 7 these findings were largely ignored by the field of antibody production and it was not until the 8 second half of the last century that publications dealing with the generation and use of 9 specific avian egg yolk immunoglobulins began to sporadically appear (e.g. Lösch et al. 1986 , 10
Polson et al. 1980 , Viereira et al. 1984 . Increasing public concern about the use of animals in 11 the laboratory has now brought the potential of avian antibodies back into focus (Lian et al., 12 2011). The production and extraction of polyclonal antibodies in chicken egg yolks has been 13 termed 'IgY-technology' (Staak in 1995, Schade and Hlinak, 1996) . In addition to animal 14 protection aspects of non-invasive extraction from egg yolk, the avian antibody IgY ('Y' now 15 commonly indicating an origin in yolk) has several other advantages, in particular those 16 resulting from the phylogenetic distance of the avian immune-system from that of mammals. in protein gel loading buffer, denatured by heating at 95°C for 10 minutes and subjected to 2 SDS-PAGE. IL-1-V5 and IL-6-V5 were detected by Western blot using V5-specific HRPO-3 conjugated antibody (Life technologies Ltd., Germany). BoNT A1 was detected using the 4 αBoNT A1 heavy chain monoclonal antibody clone A1688 (Pauly et al. 2009b) diluted at 5 250 ng/ml Blocking buffer followed by an HRPO-conjugated α-mouse polyclonal serum 6 (AbD Serotec, Germany). As positive control, purified BoNT/A1 (Metabiologics, Madison, 7 WI, USA) has been used in parallel and inactivated by SDS-treatment prior to loading onto 8 the gel. 9 10 2.4 DNA immunization by gene gun 11
Plasmid coated gold particles were prepared according to the manufacturers recommendations 12 (BioRad). Hens were immobilized horizontally to expose the breast muscle regions of the 13 apteria-area selected for immunization, with any remaining plumage being removed by hand 14 to avoid interference with the trajectory of the gold particles. The gene gun was set up to give 15 a helium gas discharge of 300 psi and positioned near the skin at the standard proximity (as 16 determined by a spacer with a circular contact area of approximately 2 cm 2 mounted on the 17 barrel). Four isolated immunization 'shots' (a total of 4 µg DNA) were applied to each 18 animal, two on the left and two on the right of the breast muscle. To maintain levels of total 19 DNA, empty pTH vector was included for animals (H96 / H97) not receiving a cytokine. The 20 whole procedure took five minutes or less and hens appeared to be only minimally affected. 21
Booster immunizations were repeated regularly every 3-4 weeks to give a total of 15 22 immunizations. 23 24
Egg sampling and IgY preparation 25
Each third or fourth egg was sampled and stored at 4 o C until further processing. Eggs were 26 processed no later than three months after collection as longer periods of storage can result in 27 yolk skins rupturing when rolled on filter paper (Pauly et al. 2011). Total IgY (tIgY) was 28 purified using a method adapted from Polson et al. (Polson et al. 1980 ). Briefly, egg yolk was 29 diluted 1:2 in sterile phosphate-buffered saline (PBS, pH 7.4, Roche, Germany) and 3.5% 30 (w/v) polyethylene glycol 6000 (PEG 6000, Roth, Germany) was added to eliminate lipids 31 and lipoproteins. After gentle shaking followed by centrifugation (10,000 × g for 20 min at 32 4 o C), the supernatant was decanted, solid PEG 6000 was added to a final concentration of 33 12% and the mixture was again centrifuged. The precipitate was then dissolved in 10 ml PBS, 34 7 PEG was added to 12% and the suspension centrifuged once more. Finally, the precipitate 1 was dissolved in 1.2 ml PBS, transferred into a QuixSep Micro Dialysis device (Roth, 2 Germany) and dialyzed against PBS at 4°C to give a final volume of around 2 ml. Adsorption 3 at 280 nm was measured photometrically and protein content calculated according to the 4 Lambert-Beer law with an extinction coefficient of 1.33 for tIgY. Previous observations 5 showed extraordinary stability of IgY stored over extensive periods (years) at various 6 temperatures between +4°C and -24°C without loss of activity (Schade et al., 2000) . 7
Generated preparations were stored in aliquots at optimal conditions of -24°C. BoNT A1 heavy chain (Fig. 1A) . As positive control, clostridial di-chain BoNT/A1 was used, 20 which is reduced under the experimental conditions into the 100 kDa heavy chain and the 50 21 kDa light chain, of which the former is detected by the monoclonal antibody A1688 (Fig. 1A ) 22
These results demonstrate that a full-length holotoxoid is efficiently expressed in cells 23 transfected with the pTH-BoNT-A1-RYM-V5 vector. 24
One of the major goals of the study was to investigate the effects of avian IL-1 and IL-6 25 when used as DNA adjuvants. Codon-optimized versions of these cytokine genes carrying a 26 C-terminal V5-tag were therefore synthesized and cloned into the pTH vector. 
Immunization scheme and monitoring of laying capacity 2
Animals were immunized by an initial priming with DNA followed by booster shots at 3 intervals of 3-4 weeks. These intervals were chosen on the basis of previous mouse 4 experiments performed to determine an optimal prime-boost regimen (data not shown). Each 5 group of hens consisted of one Lohmann brown and one Lohmann selected Leghorn (white) 6 to exclude any breed-specific influences. 7
A laying hen has normally a capacity of 5-7 eggs per week for a period of around 72 weeks, 8 after which a decrease in laying capacity usually occurs. As shown in Fig. 2 , laying capacities 9
were not affected by the gene gun procedure itself since rates remained stable on the days 10 following immunization. Whereas hens immunized with BoNT A1 (96 and 97) showed a 11 regular laying capacity, the laying capacity of those treated with IL-1 in addition to BoNT 12 A1 (hens 100 and 101) was exceptionally prolonged and at a very high level, with both 13 constantly producing between 5 and 7 eggs per week over the whole observation period (Fig.  14   2A) . Indeed, as shown in figure 2B , the difference in the mean laying capacities of the two 15 groups was statistically highly significant (Mann Whitney test, P<0.0001). Hens 98/99 16 (treated with BoNT A1 plus IL-6) were not included in this analysis because hen 98 had 17 "laying problems" from the beginning ( Fig. 2A) . 18 19
Total IgY-monitoring 20
The pattern of total IgY (tIgY) varied according to the individual hen. Although in general, 21 tIgY in all hens oscillated considerably (Fig. 3A) , the trend for hen 96 showed a statistically 22 significant increase in tIgY over the course of the study ( and December (Fig. 3A) . The mean tIgY values also varied from hen to hen (Fig. 3C) , 26 although the often significant differences did not appear to be an outcome of the type of 27 immunization. Hen 101 has somewhat less IgY per egg compared with the eggs of other hens 28 (P<0.005, Mann Whitney test) The other differences in tIgY are also quite significant (hen 96 29 to hen 97, P<0.0001; hen 97 to hen 99, P<0.0001; hen 99 to hen 100, P<0.0001, Mann 30 Whitney test). However, these differences are largely individual variations and do not reflect 31 differences related to the received immunizations, since for example the eggs of hen 100 32 receiving the IL-1 adjuvant contain a significantly higher amount of tIgY than the eggs of 33 hen101 (Fig. 3C) . Thus, the tIgY content is not significantly influenced by the immunizations 34 performed. Similarly, no differences in tIgY between the brown and white hens were 1 observed. 2 3
Development of anti-BoNT A1 IgY 4
Production of BoNT A1-specific IgY in the eggs was analyzed by ELISA. In general, hens 96 5 and 97 (BoNT A1 alone) developed the lowest levels of specific antibody (Fig. 4A ). Hen 96 6 reacted with a gradual increase after the second booster immunization, with the titer persisting 7 at a low level and a new transient peak occurring after the fifth boost. However, the titer then 8 declined and the animal did not respond to further booster shots. Hen 97 showed a similar 9 pattern of antibody development, with a slow transient increase observed after the second and 10 fifth boosts. Hens 98 and 99 (BoNT A1 combined with IL-6) showed a quite different pattern 11 of antibody development (Fig. 4A) . Although, due to sporadic laying, only a few data points 12
were obtained for hen 98, this animal already developed specific antibodies after the initial 13 immunization and responded moderately to the forth boost and strongly to the eighth. Hen 99 14 developed a low transient peak in antibody titer after the first immunization followed by a 15 strong increase after the third and fourth boosts after which antibody levels plateaued for 16 several weeks. The titers then declined gradually to the end of the study interrupted by only 17 minor reactions to the immunizations. Hens 100 and 101 (BoNT A1 combined with L) 18
showed relatively late but strong responses to the DNA immunizations (Fig. 4A) . Hen 100 19 responded to the third boost with a slow but persistent increase in titer, a dramatic increase 20 following the sixth boost and relatively prolonged peaks following the eight, tenth and twelfth 21 boosts. Hen 101 had an unexpectedly delayed response to gene gun immunization with the no 22 significant development of BoNT A-specific antibodies occurring before the tenth booster 23 immunization. The titer then dropped before rising again in response to the twelfth boost 24 (albeit to a lower level). On average, the BoNT A1-specific immune responses were almost 4 25 times increased in hens receiving the IL-6 adjuvants compared to animals receiving the 26 immunogen alone (Fig. 4B) . Application of the IL 1 showed only a slight difference and an 27 elevation in the specific titer of 1. 
